We recently announced the closing of a Series A financing round. The funds will be used to grow our operational and sales footprint in North America and to accelerate the development of our predictive analytics platform.
The round was led by Pitango Venture Capital, and the fund’s Managing General Partner Ittai Harel, is joining the company company’s Board of Directors.
Our platform uses predictive analytics and machine learning for the early detection of life-threatening complications in critical care. We provide accurate predictive clinical analytics that staff and management can use to avoid deteriorations, save lives as well as lock-in operational and financial benefits.
Studies like the one recently announced at HIMSS to date show that the CLEW (previously known as Intensix)solution has the potential to significantly improve clinical outcomes and reduce the average length of hospital stay.